Therefore, recent studies have attempted to research novel anticancer drugs that can enhance the sensitivity (effective sensitizers) of cancer cells to TRAIL [8, 9], in order to overcome TRAIL resistance in cancer cells. The gene discussed is TNFSF10; the disease is cancer.